Article
Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2
28 Jan 2023
Abstract excerpt
COVID-19, caused by the coronavirus SARS-CoV-2, represents a serious worldwide health issue, with continually emerging new variants challenging current therapeutics. One promising alternate therapeutic avenue is represented by nanobodies, small single-chain antibodies derived from camelids with numerous advantageous properties and the potential to neutralize the virus. For identification and characterization of a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
